Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3538 publications
United States Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - NPWT Rental ... -level profiles of key companies operating within the United States Negative Pressure Wound Therapy. Key players covered include Kinetic Concepts, ...

Oct, 2014 39 pages
United States Compression Therapy Market Outlook to 2020 US$ 2,500.00

... Market Outlook to 2020', provides key market data on the United States Compression Therapy market. The report provides value, in millions of US dollars, volume ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 81 pages
United Kingdom Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... Therapy market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - NPWT Rental ... -level profiles of key companies operating within the United Kingdom Negative Pressure Wound Therapy. Key players covered include Kinetic Concepts, ...

Oct, 2014 36 pages
United Kingdom Compression Therapy Market Outlook to 2020 US$ 2,500.00

... Market Outlook to 2020', provides key market data on the United Kingdom Compression Therapy market. The report provides value, in millions of US dollars, volume ... wherever available. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based ...

Oct, 2014 67 pages
Spain Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... ) Market Outlook to 2020', provides key market data on the Spain Negative Pressure Wound Therapy market. The report provides value, in millions of US dollars, ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 35 pages
South Korea Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... and forecast to 2020. 2013 company shares and distribution shares data for Negative Pressure Wound Therapy market. Global corporate-level profiles of key companies operating within the South Korea Negative Pressure Wound Therapy. Key players covered include Kinetic Concepts, Inc., ...

Oct, 2014 34 pages
Russia Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... ) Market Outlook to 2020', provides key market data on the Russia Negative Pressure Wound Therapy market. The report provides value, in millions of US dollars, ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 31 pages
Mexico Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... ) Market Outlook to 2020', provides key market data on the Mexico Negative Pressure Wound Therapy market. The report provides value, in millions of US dollars, ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 34 pages
Japan Negative Pressure Wound Therapy (NPWT) Market Outlook to 2020 US$ 2,500.00

... ) Market Outlook to 2020', provides key market data on the Japan Negative Pressure Wound Therapy market. The report provides value, in millions of US dollars, ... patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated ...

Oct, 2014 35 pages
France Compression Therapy Market Outlook to 2020 US$ 2,500.00

... GlobalData’s new report, 'France Compression Therapy Market Outlook to 2020', provides key market data on the France Compression Therapy market. The report ... Innothera. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. ...

Oct, 2014 67 pages
Global Gene Therapy Market & Pipeline Insight US$ 2,400.00

... with major research and developments breakthroughs, the global market opportunity for gene therapy is expected to reach USD 500 million by 2020. ... by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline: 69 Drugs ...

Oct, 2014 949 pages
Global Proton Therapy Market 2014-2018 US$ 2,500.00

... for the treatment of cancer using the proton beam therapy. TechNavio's report, Global Proton Therapy Market 2014-2018, has been prepared based on ... DRIVER Technological Advancement For a full, detailed list, view our report MARKET CHALLENGE High Cost of Treatment For a full, detailed list, view our ...

Oct, 2014 63 pages
Global RNA Based Therapeutics Market (Technology, Application, End Users and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report,... US$ 4,515.00

... Cenix BioScience GmbH (Germany) are some of the key players in this market. ISIS pharmaceuticals, Inc. (USA) has focused its research activities ... of key leaders, partnerships, acquisitions and clinical trials in the RNA based therapeutics market would be informative for professionals in the corporate sector ...

Sep, 2014 140 pages
United States – Pain Management Therapeutics Patients & Market Analysis US$ 1,100.00

... a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and ... the basis of: I. United States Pain Management Therapeutics Market from the year 2005 – 2018 II. United States Pain Management Patients Population from ...

Oct, 2014 73 pages
KOL Insight: Multiple Sclerosis US$ 6,495.00

... the disease? Multiple Sclerosis – Oral therapy takes centre stage is a comprehensive Therapy Trends report packed with knowledgeable opinions and insights of 12 leading ... results will be covered with primary market research with preeminent KOLs Each Update Bulletin provides Therapy Trends clients with fresh ...

Oct, 2014
Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Aileron Therapeutics, Inc. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Aileron Therapeutics, Inc.’s pipeline products Reasons ...

Sep, 2014 25 pages
Hyperemia Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... 2014 SUMMARY GlobalData's clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014" provides data on the Hyperemia clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Sep, 2014 53 pages
Payer Insights: Hepatitis C US$ 6,495.00

... regimens, share data on clinical benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare ... in public/private managed care organisations across the US Includes candid payer opinion that can help shape your plans and modify ...

Sep, 2014
Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting US$ 4,995.00

... business intelligence provider, has released its latest research, ‘Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable ... failure rates and pipeline analysis, and analysis of deals relevant to Non-Hodgkin Lymphoma (NHL). The market in the APAC region was worth ...

Sep, 2014 96 pages
Recombinant Therapeutic Proteins Market & Pipeline Analysis US$ 2,400.00

... industry. In terms of segments, the major revenue-generating segments of the recombinant therapeutic protein market include monoclonal antibody, Insulin, Interferon Beta, G-CSF ... which are likely to be the future revenue generators for this market include the Asian and Middle-Eastern region, which is having ...

Sep, 2014 899 pages
Phenex Pharmaceuticals AG - Product Pipeline Review - 2014 US$ 1,500.00

... The report reviews current pipeline of Phenex Pharmaceuticals AG’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the Phenex Pharmaceuticals AG’s pipeline products ...

Sep, 2014 27 pages
Global Gene Therapy Market Outlook 2018 US$ 1,500.00

... to boost the growth. According to RNCOS’ new research report “Global Gene Therapy Market Outlook 2018”, a major focus has been on the ongoing ... . Finally, with a view to understanding the competitive landscape, the profiles of key market players have been included in the report to present a complete picture of ...

Sep, 2014 125 pages
SomaGenics Inc. - Product Pipeline Review - 2014 US$ 1,500.00

... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the SomaGenics Inc.’s pipeline products ... drug targets and therapeutic classes in the SomaGenics Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas Exploit ...

Aug, 2014 21 pages
Medeia Therapeutics Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Medeia Therapeutics Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Medeia Therapeutics Ltd.’s pipeline products Reasons to ...

Aug, 2014 25 pages
Mabion SA - Product Pipeline Review - 2014 US$ 1,500.00

... - 2014 Summary Global Markets Direct’s, ‘Mabion SA - Product Pipeline Review - 2014’, provides an overview of the Mabion SA’s pharmaceutical research and development focus. ... and enlists all their major and minor projects The report features product description and descriptive mechanism of action for key ...

Aug, 2014 29 pages
BiOrion Technologies B.V. - Product Pipeline Review - 2014 US$ 1,500.00

... The report reviews current pipeline of BiOrion Technologies B.V.’s human therapeutic division and enlists all their major and minor projects The report ... the dormant and discontinued pipeline projects Latest company statement Latest news and deals relating to the BiOrion Technologies B.V.’s pipeline products ...

Aug, 2014 19 pages
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM US$ 4,995.00

... provider, has released its latest research, "Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM", which provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the ...

Aug, 2014 105 pages
ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations US$ 4,995.00

... Summary GBI Research has released the pharma report, “ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive ... for an additional duration, representing an unmet need within this growing ADHD segment. The current developmental pipeline addresses these gaps in the ...

Jul, 2014 91 pages
Global Antifungal Therapeutics Market:Trends and Opportunities (2014-2019) US$ 800.00

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with ... respective classes. It also assesses the key opportunities and underlying trends in the market and outlines the factors that are and will ...

Aug, 2014 65 pages
Astraea Therapeutics, LLC - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Astraea Therapeutics, LLC including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Astraea Therapeutics, LLC’s pipeline products Reasons ...

Jul, 2014 18 pages
Global Hodgkins Lymphoma Therapeutics Market 2014-2018 US$ 2,500.00

... treatment for the condition. TechNavio's analysts forecast the Global Hodgkin's Lymphoma Therapeutics market will grow at a CAGR of 6.84 percent over the period ... report also includes a discussion of the Key Vendors operating in this market. Key Regions Americas APAC EMEA Key Vendors Bristol Myers ...

Aug, 2014 79 pages
Allergic Asthma-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Allergic Asthma-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Adult Malignant Glioma -Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Adult Malignant Glioma -Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Adenovirus Infections-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Adenovirus Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Adenovirus Infections. This report provides ...

Aug, 2014
Acute Spinal Cord Injury-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Spinal Cord Injury-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Acute Ischemic Stroke-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Ischemic Stroke-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Acute Bacterial Sinusitis-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acute Bacterial Sinusitis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Actinic Keratosis-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Actinic Keratosis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Actinic Keratosis. This ...

Aug, 2014
Acne Vulgaris-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Acne Vulgaris-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Abscess-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Opsona Therapeutics Ltd. - Product Pipeline Review - 2014 US$ 1,500.00

... disease. Scope The report provides brief overview of Opsona Therapeutics Ltd. including business description, key information and facts, and its ... and discontinued pipeline projects Latest company statement Latest news and deals relating to the Opsona Therapeutics Ltd.’s pipeline products Reasons to ...

Jul, 2014 25 pages
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2014 US$ 2,500.00

... Review, H2, 2014' provides data on the Obsessive-Compulsive Disorder clinical trial scenario. This report provides elemental information and data relating ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Jul, 2014 79 pages
Keratitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Keratitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Iron Deficiency Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Insomnia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Influenza- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Influenza- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

... SUMMARY DelveInsight’s, “ Inflammation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Indigestion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Indigestion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... (US DMF) available for Phase III Pipeline Drugs. Key discontinued Marketed products. Global Sales Figure from 2011-2015. Reasons to buy ...

Jul, 2014
Hyperlipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 US$ 2,000.00

SUMMARY DelveInsight’s, “ Hyperlipidemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about ... the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. ...

Jul, 2014
1 2 3 4 5 >
Skip to top